p53 mutations in BRCA1-associated familial breast cancer

Lancet

Volumn 352, Issue 9128, 1998, Pages 622-

  Schlichtholz, Beata ^b   Bouchind'homme, Brigitte ^b   Pagés, Sabinne ^b   Martin, Emmanuel ^b   Liva, Stéphane ^b   Magdelenat, Henri ^b   Sastre Garau, Xavier ^b   Stoppa Lyonnet, Dominique ^b   Soussi, Thierry ^a  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DNA; PROTEIN P53;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GENETIC LINKAGE; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL;

EID: 0032558295     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79576-3     Document Type: Article

References (5)

1. 1 Crook T, Crossland S, Crompton MR, Osin P, Gusterson BA. p53 mutations in BRCA1-associated familiar breast cancer. Lancet 1997; 350: 638-39.
2. 2 Nordgren H, Lindgren A, Bergh J. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry - response. J Natl Cancer Inst 1996; 88: 1500.
3. 3 Hartmann A, Blaszyk H, Kovach JS, Sommer SS. The molecular epidemiology of P53 gene mutations in human breast cancer. Trends Genet 1997; 13: 27-33.
4. 4 Zelada-Hedman M, Borresen-Dale AL, Claro A, Chen J, Skoog L, Lindblom A. Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families. Br J Cancer 1997; 75: 1201-04.
5. 5 Soussi T. The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 1996; 2: 32-37.